Anixa Biosciences (ANIX) News Today $3.21 -0.02 (-0.62%) As of 07/7/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANIX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Anixa Biosciences (NASDAQ:ANIX) Trading Down 0.6% - Here's Why4 hours ago | marketbeat.comANIX - Anixa Biosciences Inc Dividends - MorningstarJune 24, 2025 | morningstar.comMAnixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical TrialJune 23, 2025 | prnewswire.comPreventing Cancer Before It Starts: New Vaccine Could Revolutionize The Fight Against Breast CancerJune 21, 2025 | msn.comAnixa Biosciences to Host an Investor Webcast on June 26, 2025June 20, 2025 | prnewswire.comBreast cancer vaccine shows promising results in phase 1 clinical trialsJune 19, 2025 | msn.comBreast cancer vaccine showing progressJune 17, 2025 | msn.comAnixa Biosciences (NASDAQ:ANIX) Receives Buy Rating from D. Boral CapitalJune 10, 2025 | marketbeat.comAnixa Biosciences' Breast Cancer Vaccine Receives National News CoverageJune 10, 2025 | prnewswire.comBreakthrough vaccine could eradicate breast cancer, shows 75% immune response in trialJune 9, 2025 | msn.comAnixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025June 9, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Rating Increased to Hold at Wall Street ZenJune 6, 2025 | marketbeat.comAnixa Biosciences, Inc. (NASDAQ:ANIX) CEO Amit Kumar Acquires 10,000 SharesJune 6, 2025 | insidertrades.comH.C. Wainwright maintains Buy rating on Anixa Biosciences stockJune 6, 2025 | uk.investing.comAnixa Biosciences, Inc. (NASDAQ:ANIX) CEO Buys $28,500.00 in StockJune 5, 2025 | marketbeat.comHC Wainwright Lifts Earnings Estimates for Anixa BiosciencesJune 5, 2025 | marketbeat.comAnixa Biosciences' Breast Cancer Vaccine Featured in NewsNation InterviewJune 3, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Announces Quarterly Earnings ResultsJune 3, 2025 | marketbeat.comAnixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer VaccineJune 2, 2025 | prnewswire.comBreast cancer vaccine enters second trial phase | Elizabeth Vargas ReportsMay 31, 2025 | msn.comBreast cancer vaccine moving to critical phaseMay 31, 2025 | msn.comD. Boral Capital Reaffirms "Buy" Rating for Anixa Biosciences (NASDAQ:ANIX)May 30, 2025 | marketbeat.comAnixa Biosciences (ANIX) Expected to Announce Earnings on TuesdayMay 28, 2025 | marketbeat.comAnixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative MilestonesMay 19, 2025 | prnewswire.comAnixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 12, 2025 | prnewswire.comAnixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20thApril 30, 2025 | prnewswire.comAnixa Biosciences receives notice of allowance for new patent from USPTOApril 15, 2025 | markets.businessinsider.comAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property PortfolioApril 14, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Earns Buy Rating from D. Boral CapitalApril 12, 2025 | marketbeat.comAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine TechnologyApril 9, 2025 | prnewswire.comAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine TechnologyApril 9, 2025 | prnewswire.comAnixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9thApril 1, 2025 | prnewswire.comEquities Analysts Set Expectations for ANIX Q1 EarningsMarch 27, 2025 | marketbeat.comAnixa Biosciences to develop AI-guided cancer vaccines with Verdi SolutionsMarch 26, 2025 | markets.businessinsider.comAnixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at HC WainwrightMarch 26, 2025 | marketbeat.com1ANIX : EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI...March 25, 2025 | benzinga.comAnixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer VaccinesMarch 25, 2025 | prnewswire.comAnixa receives notice of allowance from USPTO for ovarian cancer vaccineMarch 24, 2025 | markets.businessinsider.comAnixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer VaccineMarch 24, 2025 | prnewswire.comAnixa Biosciences initiated with a Buy at MaximMarch 22, 2025 | markets.businessinsider.comMaxim Group Initiates Coverage of Anixa Biosciences (ANIX) with Buy RecommendationMarch 22, 2025 | msn.comMaxim Group Initiates Coverage on Anixa Biosciences (NASDAQ:ANIX)March 22, 2025 | marketbeat.comAnixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28thMarch 17, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Posts Earnings ResultsMarch 12, 2025 | marketbeat.comAnixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested PartiesMarch 10, 2025 | prnewswire.comAnixa Biosciences (ANIX) to Release Earnings on TuesdayMarch 10, 2025 | marketbeat.comAnixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19thMarch 3, 2025 | prnewswire.comSpotlight On February 2025's Promising Penny StocksFebruary 27, 2025 | finance.yahoo.comAnixa Biosciences, Inc.: Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical TrialFebruary 27, 2025 | finanznachrichten.deAnixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical TrialFebruary 26, 2025 | prnewswire.com Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address ANIX Media Mentions By Week ANIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIX News Sentiment▼0.000.57▲Average Medical News Sentiment ANIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIX Articles This Week▼12▲ANIX Articles Average Week Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Precigen News Rapport Therapeutics News Oruka Therapeutics News PureTech Health News REGENXBIO News Tourmaline Bio News Eton Pharmaceuticals News iTeos Therapeutics News Rezolute News Revance Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Anixa Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANIX Stock Alerts